Literature DB >> 11283064

Pediatric solid-organ transplant recipients carry chronic loads of Epstein-Barr virus exclusively in the immunoglobulin D-negative B-cell compartment.

C Rose1, M Green, S Webber, D Ellis, J Reyes, D Rowe.   

Abstract

Solid-organ transplant recipients are at risk for development of lymphoproliferative diseases. The purpose of this study was to examine the distribution of Epstein-Barr virus (EBV) load in the peripheral blood of pediatric transplant recipients who had become chronic viral load carriers (>8 copies/10(5) lymphocytes for >2 months). A total of 19 patients with viral loads ranging from 20 to 5,000 viral genome copies/10(5) lymphocytes were studied. Ten patients had no previous diagnosis of posttransplant lymphoproliferative disease (PT-LPD), while nine had recovered from a diagnosed case of PT-LPD. No portion of the peripheral blood viral load was detected in the cell-free plasma fraction. Viral DNA was found in a population of cells characterized as CD19(hi) and immunoglobulin D negative, a phenotype that is consistent with the virus being carried exclusively in the memory B-cell compartment of the peripheral blood. There was no difference in the compartmentalization based upon either the level of the viral load or the past diagnosis of an episode of PT-LPD. These results have implications for the design of tests to detect EBV infection and for the interpretation and use of positive EBV PCR assays in the management of transplant recipients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11283064      PMCID: PMC87947          DOI: 10.1128/JCM.39.4.1407-1415.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  24 in total

1.  Epstein-Barr virus gene expression in the peripheral blood of transplant recipients with persistent circulating virus loads.

Authors:  L Qu; M Green; S Webber; J Reyes; D Ellis; D Rowe
Journal:  J Infect Dis       Date:  2000-09-08       Impact factor: 5.226

2.  Is EBV persistence in vivo a model for B cell homeostasis?

Authors:  G Khan; E M Miyashita; B Yang; G J Babcock; D A Thorley-Lawson
Journal:  Immunity       Date:  1996-08       Impact factor: 31.745

3.  Characterization of EBV-carrying B-cell populations in healthy seropositive individuals with regard to density, release of transforming virus and spontaneous outgrowth.

Authors:  N Lewin; P Aman; M G Masucci; E Klein; G Klein; B Oberg; H Strander; W Henle; G Henle
Journal:  Int J Cancer       Date:  1987-04-15       Impact factor: 7.396

4.  Lymphocyte subpopulations do not alter during blood storage at 4 degrees C.

Authors:  R Van Lambalgen; G J Van Meurs
Journal:  J Immunol Methods       Date:  1985-06-12       Impact factor: 2.303

Review 5.  A model for persistent infection with Epstein-Barr virus: the stealth virus of human B cells.

Authors:  D A Thorley-Lawson; G J Babcock
Journal:  Life Sci       Date:  1999       Impact factor: 5.037

Review 6.  The management of Epstein-Barr virus associated post-transplant lymphoproliferative disorders in pediatric solid-organ transplant recipients.

Authors:  M Green; M G Michaels; S A Webber; D Rowe; J Reyes
Journal:  Pediatr Transplant       Date:  1999-11

7.  Reference ranges for lymphocyte subsets in pediatric patients.

Authors:  P K Kotylo; N S Fineberg; K S Freeman; N L Redmond; C Charland
Journal:  Am J Clin Pathol       Date:  1993-08       Impact factor: 2.493

8.  Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients.

Authors:  S A Riddler; M C Breinig; J L McKnight
Journal:  Blood       Date:  1994-08-01       Impact factor: 22.113

9.  A novel form of Epstein-Barr virus latency in normal B cells in vivo.

Authors:  E M Miyashita; B Yang; K M Lam; D H Crawford; D A Thorley-Lawson
Journal:  Cell       Date:  1995-02-24       Impact factor: 41.582

Review 10.  Age-related changes in T- and B-lymphocyte subpopulations in the peripheral blood.

Authors:  M J Hicks; J F Jones; L L Minnich; K A Weigle; A C Thies; J M Layton
Journal:  Arch Pathol Lab Med       Date:  1983-10       Impact factor: 5.534

View more
  5 in total

1.  Decreased NKp46 and NKG2D and elevated PD-1 are associated with altered NK-cell function in pediatric transplant patients with PTLD.

Authors:  Silke Wiesmayr; Steven A Webber; Camila Macedo; Iulia Popescu; Louise Smith; Jane Luce; Diana Metes
Journal:  Eur J Immunol       Date:  2011-12-16       Impact factor: 5.532

2.  EBV-specific CD8+ T cells from asymptomatic pediatric thoracic transplant patients carrying chronic high EBV loads display contrasting features: activated phenotype and exhausted function.

Authors:  Camila Macedo; Steven A Webber; Albert D Donnenberg; Iulia Popescu; Yun Hua; Michael Green; David Rowe; Louise Smith; Maria M Brooks; Diana Metes
Journal:  J Immunol       Date:  2011-04-01       Impact factor: 5.422

3.  Surface immunoglobulin-deficient Epstein-Barr virus-infected B cells in the peripheral blood of pediatric solid-organ transplant recipients.

Authors:  Elizabeth Schauer; Steven Webber; Michael Green; David Rowe
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

4.  Detection of Epstein-Barr virus genomes in peripheral blood B cells from solid-organ transplant recipients by fluorescence in situ hybridization.

Authors:  Camille Rose; Michael Green; Steven Webber; Lawrence Kingsley; Roger Day; Simon Watkins; Jorges Reyes; David Rowe
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

5.  Limited Utility of Serology and Heterophile Test in the Early Diagnosis of Epstein-Barr Virus Mononucleosis in a Child after Renal Transplantation.

Authors:  Alexandra Byrne; Rachel Bush; Felicia Johns; Kiran Upadhyay
Journal:  Medicines (Basel)       Date:  2020-04-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.